Hypertension

Adding liraglutide to insulin treatment for type 1 diabetes has proven to lower body weight and reduce the frequency of hypoglycemia. Potential heart risks, however, have yet to be established.

What happens when a patient with type 2 diabetes uses both a potassium (K)-sparing agent and sodium-glucose co-transporter 2 (SGLT2) inhibitor at the same time?

The combination of nebivolol/valsartan (Byvalson) lowers blood pressure better than either drug by themselves.

When treating patients with a variety of conditions it can be easy for the lines of care to be blurred, this is particularly true when treating patients with conditions like diabetes and heart failure among others.

Treating patients with diabetes can be enough of a challenge for doctors, add in the comorbidity of cardiac conditions as well and the work gets that much harder to navigate for even the most veteran clinicians.

Will more aggressive BP control reduce the risk of CV outcomes? Finally, some answers.

Resistant hypertension? A hypertensive emergency? Select your strategy and then find out if the evidence supports it.

Men diagnosed with multiple sclerosis often have higher blood pressure than women, in addition to higher levels of diabetes, epilepsy, depression, and anxiety.

The practice of CVD risk estimation shifted radically in 2013. The ACC-AHA app helps you connect the new dots.

Despite recently approved medications showing improvement over previously used diet pills and other treatments there is still no medicinal cure for obesity and the best hope for patients in many cases is lifestyle changes.

The US Food and Drug Administration recently approved some new tools in the fight against obesity. While they provide some help for patients looking to lose weight there are also side effects which doctors and patients patients to consider.

Medical science and research has helped move many parts of cardiology from potentially fatal conditions to more chronic issues for patients and doctors to address. Cholesterol control is moving in that direction thanks to new advancements in medication and surgical options.

Patients with type 2 diabetes mellitus (T2DM) are at risk of developing high blood pressure, which can cause renal and cardiovascular complications. Thus, a T2DM treatment plan must include blood pressure treatment.

HDL and LDL may be the more well known components of a patient's cholesterol level but as researchers dig deeper new information is coming to light about very low-density lipoprotein or VLDL.

There are many ways patients can better manage their cholesterol than they could just a few years ago. Whether they are successful in those efforts and the role of doctors and medications in that process remains to be seen.

As the debate continues between good cholesterol and bad cholesterol researchers are looking for answers on how to help patients manage their cholesterol levels.

Our cardiologist blogger highlights PARTNER-2, HOPE-3, and sessions on women in cardiology at ACC.16.

Even as technology improves to help patients dealing with cardiovascular disease, those responsible for the procedures also must consider providing treatment while weighing the costs of that work.

Since its inception nearly a decade ago the PARTNER trials have shown new opportunities for cardiovascular disease patients to receive treatment they may not have been candidates for before.

The American College of Cardiology's outgoing President Kim A. Williams, MD, went vegan in 2003 and never looked back. He talks about the diet's power to heal and how being the ACC's first vegan leader played out.

As one of the components of the CHADS2 score diabetes is a known risk for stroke. A recent study looked at how rivaroxaban, also known as Xarelto can help patients reduce this potentially deadly health issue.

For those how enter the field of genetic testing there are many challenges along the way, starting with finding the right training program through using that training in very difficult situations.

As more is learned about genetic conditions in cardiology more is being done to help not only to help the patients themselves but those around them as well.

There were hundreds of presentations on high-tech innovations and the latest drugs for heart disease. But unless cardiologists find better ways to prevent cardiovascular illness, deaths will keep rising, the ACC's Kim Williams, MD said in his welcome speech.

Population health—the quest to improve the physical well-being of people around the world—is increasingly focused on prevention. But giving antihypertensives plus statins to people who do not have high blood pressure has risks.

Stress directly impacts the arteries. Imaging studies enable physicians to actually see the proof, a Boston, MA team reports.

In findings that shocked the Cleveland Clinic researchers who compiled them, heart attack patients are getting younger and have more comorbidities than expected.

Treating diabetes in the frail elderly may require different treatment goals.

A Swedish trial found that weekly yoga was associated with higher quality of life, lower blood pressure and slower heart rates in patients with paroxysmal atrial fibrillation.

Find out what you know about how to avoid therapeutic inertia in treatment of hypertension.